Core Laboratories Expects Q3 Revenue Of $131M - $137M (Est $135.11M), EPS Of $0.23 - $0.27 (Est $0.25)
Portfolio Pulse from Benzinga Newsdesk
Core Laboratories (CLB) has provided its Q3 revenue guidance of $131M - $137M, which is in line with the estimated $135.11M. The company also expects EPS to be between $0.23 and $0.27, matching the estimated $0.25.
July 24, 2024 | 9:21 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Core Laboratories (CLB) has issued Q3 revenue guidance of $131M - $137M, aligning with the estimated $135.11M. The EPS guidance of $0.23 - $0.27 also matches the estimated $0.25.
The revenue and EPS guidance provided by Core Laboratories is in line with market expectations. This suggests a neutral short-term impact on the stock price as there are no significant surprises.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100